Aug 14 (Reuters) - Leap Therapeutics Inc LPTX.O:
LEAP THERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
LEAP THERAPEUTICS INC - IMPLEMENTS 75% WORKFORCE REDUCTION
LEAP THERAPEUTICS INC: TOTAL COSTS RELATED TO THIS REDUCTION IN FORCE, INCLUDING SEVERANCE PAYMENTS, ARE ESTIMATED TO BE ABOUT $4.5 MILLION
LEAP THERAPEUTICS INC: MAJORITY OF THESE COSTS WILL BE RECOGNIZED IN THIRD AND FOURTH QUARTERS OF 2025